Incyte (INCY) Exchange Rate Effect (2016 - 2026)
Incyte (INCY) posted Exchange Rate Effect of -$2.7 million for Q1 2026, down 235.71% on a QoQ basis from -$801000.0 in Q4 2025, and down 387.14% year-over-year from $936484.5 in Q1 2025.
Incyte (INCY) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Incyte's Exchange Rate Effect history runs 11 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- Quarterly Exchange Rate Effect fell 387.14% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.8 million (down 226.22% YoY) and the FY2025 annual result came in at -$1.7 million, down 158.47% from the prior year.
- Exchange Rate Effect was -$2.7 million for Q1 2026 at Incyte, down from -$801000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $3.5 million in Q4 2024 and bottomed at -$7.3 million in Q4 2023.
- A 5-year average of -$282117.6 and a median of $13000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 557.03% in 2025, while the deepest fall reached 9307.69% in 2025.
- Incyte's Exchange Rate Effect stood at $627000.0 in 2022, then sank by 1264.43% to -$7.3 million in 2023, then soared by 147.36% to $3.5 million in 2024, then slumped by 123.16% to -$801000.0 in 2025, then sank by 235.71% to -$2.7 million in 2026.
- Business Quant data shows INCY's Exchange Rate Effect at -$2.7 million in Q1 2026, -$801000.0 in Q4 2025, and $841000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | -2.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.69 Mn |
| Mar 31, 2026 | -2.69 Mn |
| Dec 31, 2025 | -801,000.00 |
| Dec 31, 2025 | -801,000.00 |
| Sep 30, 2025 | 841,000.00 |
| Sep 30, 2025 | 841,000.00 |
| Jun 30, 2025 | -1.20 Mn |
| Jun 30, 2025 | -1.20 Mn |
| Mar 31, 2025 | -552,000.00 |
| Mar 31, 2025 | -552,000.00 |
| Dec 31, 2024 | 3.46 Mn |
| Dec 31, 2024 | 3.46 Mn |
| Sep 30, 2024 | 128,000.00 |
| Sep 30, 2024 | 128,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | -676,000.00 |
| Mar 31, 2024 | -676,000.00 |
| Dec 31, 2023 | -7.30 Mn |
| Dec 31, 2023 | -7.30 Mn |